These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12123810)

  • 61. Differential dose-dependent effects of epidermal growth factor on gene expression in A431 cells: evidence for a signal transduction pathway that can bypass Raf-1 activation.
    Silvy M; Martin PM; Chajry N; Berthois Y
    Endocrinology; 1998 May; 139(5):2382-91. PubMed ID: 9564849
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Apigenin and LY294002 prolong EGF-stimulated ERK1/2 activation in PC12 cells but are unable to induce full differentiation.
    Llorens F; Garcia L; Itarte E; Gómez N
    FEBS Lett; 2002 Jan; 510(3):149-53. PubMed ID: 11801244
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Regulation of p42 mitogen-activated-protein kinase activity by protein phosphatase 2A under conditions of growth inhibition by epidermal growth factor in A431 cells.
    Chajry N; Martin PM; Cochet C; Berthois Y
    Eur J Biochem; 1996 Jan; 235(1-2):97-102. PubMed ID: 8631373
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Complex phosphatase regulation of Ca2+-activated Cl- currents in pulmonary arterial smooth muscle cells.
    Ayon R; Sones W; Forrest AS; Wiwchar M; Valencik ML; Sanguinetti AR; Perrino BA; Greenwood IA; Leblanc N
    J Biol Chem; 2009 Nov; 284(47):32507-21. PubMed ID: 19767392
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Protein phosphatase 2B inhibitor potentiates endothelial PKC activity and barrier dysfunction.
    Lum H; Podolski JL; Gurnack ME; Schulz IT; Huang F; Holian O
    Am J Physiol Lung Cell Mol Physiol; 2001 Sep; 281(3):L546-55. PubMed ID: 11504680
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Regulation of large calcium-activated potassium channels by protein phosphatase 2A.
    Sansom SC; Stockand JD; Hall D; Williams B
    J Biol Chem; 1997 Apr; 272(15):9902-6. PubMed ID: 9092528
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Extracellular signal regulated kinase 5 mediates signals triggered by the novel tumor promoter palytoxin.
    Charlson AT; Zeliadt NA; Wattenberg EV
    Toxicol Appl Pharmacol; 2009 Dec; 241(2):143-53. PubMed ID: 19716839
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Protein phosphatase activity is required for light-inducible gene expression in maize.
    Sheen J
    EMBO J; 1993 Sep; 12(9):3497-505. PubMed ID: 8253076
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of okadaic acid and calyculin A on cholesterol esterification in rat hepatocytes.
    Hernández ML; López de Heredia M; Martínez MJ; Ochoa B
    Biochem Soc Trans; 1995 Nov; 23(4):580S. PubMed ID: 8654765
    [No Abstract]   [Full Text] [Related]  

  • 70. Identification of a hydrogen peroxide-induced PP1-JNK1-Sp1 signaling pathway for gene regulation.
    Chu S; Ferro TJ
    Am J Physiol Lung Cell Mol Physiol; 2006 Nov; 291(5):L983-92. PubMed ID: 16815888
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Low concentrations of the phosphatase inhibitor okadaic acid stop tumor cell locomotion.
    Niggli V; Keller H
    Eur J Pharmacol; 1997 Apr; 324(1):99-108. PubMed ID: 9137919
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Phosphatases PP1 and PP2A act after the G0/G1 interface in lymphocyte activation.
    Metcalfe S; Milner J
    Immunol Lett; 1990 Nov; 26(2):177-82. PubMed ID: 1702753
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A study of the binding requirements of calyculin A and dephosphonocalyculin A with PP1, development of a molecular recognition model for the binding interactions of the okadaic acid class of compounds with PP1.
    Volter KE; Embrey KJ; Pierens GK; Quinn RJ
    Eur J Pharm Sci; 2001 Jan; 12(3):181-94. PubMed ID: 11113637
    [TBL] [Abstract][Full Text] [Related]  

  • 74. ERK5/KLF4 signaling as a common mediator of the neuroprotective effects of both nerve growth factor and hydrogen peroxide preconditioning.
    Su C; Sun F; Cunningham RL; Rybalchenko N; Singh M
    Age (Dordr); 2014; 36(4):9685. PubMed ID: 25015774
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Phosphatase inhibition and cell survival after DNA damage induced by radiation.
    Hamilton J; Grawenda AM; Bernhard EJ
    Cancer Biol Ther; 2009 Aug; 8(16):1577-86. PubMed ID: 19571665
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Augmentation of methylprednisolone-induced differentiation of myeloid leukemia cells by serine/threonine protein phosphatase inhibitors.
    Uzunoglu S; Uslu R; Tobu M; Saydam G; Terzioglu E; Buyukkececi F; Omay SB
    Leuk Res; 1999 May; 23(5):507-12. PubMed ID: 10374865
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cellular serine/threonine phosphatase activity during human cytomegalovirus infection.
    Hakki M; Geballe AP
    Virology; 2008 Oct; 380(2):255-63. PubMed ID: 18757073
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The alpha4 regulatory subunit exerts opposing allosteric effects on protein phosphatases PP6 and PP2A.
    Prickett TD; Brautigan DL
    J Biol Chem; 2006 Oct; 281(41):30503-11. PubMed ID: 16895907
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Human cytomegalovirus phosphoproteins are hypophosphorylated and intrinsically disordered.
    Rieder FJJ; Kastner MT; Hartl M; Puchinger MG; Schneider M; Majdic O; Britt WJ; Djinović-Carugo K; Steininger C
    J Gen Virol; 2017 Mar; 98(3):471-485. PubMed ID: 27959783
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Specificity of the test based on modification of cell morphology for detection of lipophilic inhibitors of protein phosphatases.
    Pouchus YF; Amzil Z; Marcaillou-Le Baut C; James KJ; Verbist JF
    Toxicon; 1997 Jul; 35(7):1137-42. PubMed ID: 9248012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.